IndianEra > Coronavirus > When to use Remdesivir, Tocilizumab? When to do HRCT chest? Govt issues clinical guidance for Covid-19 treatment

Patients who are not on oxygen support or are in home settings should not be recommended Remdesivir, the latest clinical guidance for the management of adult Covid-19 patients says.

Classifying active Covid-19 patients into three broad groups of mild, moderate and severe, the Union health ministry has issued fresh clinical guidance for the management of adult Covid-19 patients, underlying which patients need which medication and what should not be done in a specific situation.

Ivermectin or HCQ

Clarifying that this is based on low certainty of evidence, the guideline said that Tab Ivermectin (200 mcg/kg once a day for 3 days) may be given to patients who have mild symptoms and are being treated at home.

An alternative to Ivermectin is Tab HCQ (400 mg BD 1 day f/b 400 mg OD for 4 days) unless contraindicated.

For these mild patients, inhalational Budesonide (given via Metered dose inhaler/ Dry powder inhaler) at a dose of 800 mcg BD for 5 days) may be given if symptoms (fever and/or cough) are persistent beyond 5 days of disease onset.

Share this post
CoronavirusHealthNews
Tagged , , , , , , , ,
Posted by IndianEra, 23/04/2021
Leave a Reply

Your email address will not be published. Required fields are marked *